A citation-based method for searching scientific literature

Giuliana S Zuccoli, Verônica M Saia-Cereda, Juliana M Nascimento, Daniel Martins-de-Souza. Front Neurosci 2017
Times Cited: 56







List of co-cited articles
438 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
S Prabakaran, J E Swatton, M M Ryan, S J Huffaker, J T-J Huang, J L Griffin, M Wayland, T Freeman, F Dudbridge, K S Lilley,[...]. Mol Psychiatry 2004
686
17

Defects in Bioenergetic Coupling in Schizophrenia.
Courtney R Sullivan, Sinead M O'Donovan, Robert E McCullumsmith, Amy Ramsey. Biol Psychiatry 2018
35
22

Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
Hayley B Clay, Stephanie Sillivan, Christine Konradi. Int J Dev Neurosci 2011
245
12

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.
Clare L Beasley, Kyla Pennington, Aine Behan, Robin Wait, Michael J Dunn, David Cotter. Proteomics 2006
217
10

Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications.
Ashwini Rajasekaran, Ganesan Venkatasubramanian, Michael Berk, Monojit Debnath. Neurosci Biobehav Rev 2015
127
10


Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
Courtney R Sullivan, Rachael H Koene, Kathryn Hasselfeld, Sinead M O'Donovan, Amy Ramsey, Robert E McCullumsmith. Mol Psychiatry 2019
22
22

Postmortem studies on mitochondria in schizophrenia.
Rosalinda C Roberts. Schizophr Res 2017
41
12


Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
Daniel Martins-de-Souza, Giuseppina Maccarrone, Thomas Wobrock, Inga Zerr, Philipp Gormanns, Stefan Reckow, Peter Falkai, Andrea Schmitt, Christoph W Turck. J Psychiatr Res 2010
117
8

Impaired mitochondrial function in psychiatric disorders.
Husseini Manji, Tadafumi Kato, Nicholas A Di Prospero, Seth Ness, M Flint Beal, Michael Krams, Guang Chen. Nat Rev Neurosci 2012
273
8

Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.
Michael J Gandal, Jillian R Haney, Neelroop N Parikshak, Virpi Leppa, Gokul Ramaswami, Chris Hartl, Andrew J Schork, Vivek Appadurai, Alfonso Buil, Thomas M Werge,[...]. Science 2018
428
8


A model of the mitochondrial basis of bipolar disorder.
Gerwyn Morris, Ken Walder, Sean L McGee, Olivia M Dean, Susannah J Tye, Michael Maes, Michael Berk. Neurosci Biobehav Rev 2017
71
8


Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.
Ronald Kim, Kati L Healey, Marian T Sepulveda-Orengo, Kathryn J Reissner. Prog Neuropsychopharmacol Biol Psychiatry 2018
48
10

Mitochondrial involvement in psychiatric disorders.
Ling Shao, Maureen V Martin, Stanley J Watson, Alan Schatzberg, Huda Akil, Richard M Myers, Edward G Jones, William E Bunney, Marquis P Vawter. Ann Med 2008
208
7


In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.
Fei Du, Alissa J Cooper, Thida Thida, Selma Sehovic, Scott E Lukas, Bruce M Cohen, Xiaoliang Zhang, Dost Ongür. JAMA Psychiatry 2014
56
7

Synaptic energy use and supply.
Julia J Harris, Renaud Jolivet, David Attwell. Neuron 2012
644
7

A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.
Hendrik Wesseling, Man K Chan, T M Tsang, Agnes Ernst, Fabian Peters, Paul C Guest, Elaine Holmes, Sabine Bahn. Neuropsychopharmacology 2013
37
10

Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
K Pennington, C L Beasley, P Dicker, A Fagan, J English, C M Pariante, R Wait, M J Dunn, D R Cotter. Mol Psychiatry 2008
160
7

Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder.
Jerome Mertens, Qiu-Wen Wang, Yongsung Kim, Diana X Yu, Son Pham, Bo Yang, Yi Zheng, Kenneth E Diffenderfer, Jian Zhang, Sheila Soltani,[...]. Nature 2015
275
7

Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.
Ning Cheng, Jong M Rho, Susan A Masino. Front Mol Neurosci 2017
47
8


Schizophrenia.
René S Kahn, Iris E Sommer, Robin M Murray, Andreas Meyer-Lindenberg, Daniel R Weinberger, Tyrone D Cannon, Michael O'Donovan, Christoph U Correll, John M Kane, Jim van Os,[...]. Nat Rev Dis Primers 2015
332
7

Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia.
Courtney R Sullivan, Catharine A Mielnik, Adam Funk, Sinead M O'Donovan, Eduard Bentea, Mikhail Pletnikov, Amy J Ramsey, Zhexing Wen, Laura M Rowland, Robert E McCullumsmith. Sci Rep 2019
24
16


Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression.
Josh Allen, Raquel Romay-Tallon, Kyle J Brymer, Hector J Caruncho, Lisa E Kalynchuk. Front Neurosci 2018
95
7

Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.
P Bubber, V Hartounian, G E Gibson, J P Blass. Eur Neuropsychopharmacol 2011
49
8

Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.
Giselli Scaini, Gislaine T Rezin, Andre F Carvalho, Emilio L Streck, Michael Berk, João Quevedo. Neurosci Biobehav Rev 2016
75
7

Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.
Daniel Martins-de-Souza, Wagner F Gattaz, Andrea Schmitt, Giuseppina Maccarrone, Eva Hunyadi-Gulyás, Marcos N Eberlin, Gustavo H M F Souza, Sérgio Marangoni, José C Novello, Christoph W Turck,[...]. J Psychiatr Res 2009
124
7


Proteomic characterization of hippocampus of chronically socially isolated rats treated with fluoxetine: Depression-like behaviour and fluoxetine mechanism of action.
Ivana Perić, Victor Costina, Andrijana Stanisavljević, Peter Findeisen, Dragana Filipović. Neuropharmacology 2018
16
25

Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways.
Michaela D Filiou, Yaoyang Zhang, Larysa Teplytska, Stefan Reckow, Philipp Gormanns, Giuseppina Maccarrone, Elisabeth Frank, Melanie S Kessler, Boris Hambsch, Markus Nussbaumer,[...]. Biol Psychiatry 2011
90
7

Fluoxetine reverses behavior changes in socially isolated rats: role of the hippocampal GSH-dependent defense system and proinflammatory cytokines.
Ivana Perić, Andrijana Stanisavljević, Peter Gass, Dragana Filipović. Eur Arch Psychiatry Clin Neurosci 2017
23
17

A Meta-Analysis of Oxidative Stress Markers in Depression.
Tao Liu, Shuming Zhong, Xiaoxiao Liao, Jian Chen, Tingting He, Shunkai Lai, Yanbin Jia. PLoS One 2015
175
5

The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.
Daniel Martins-de-Souza, Murtada Alsaif, Agnes Ernst, Laura W Harris, Nancy Aerts, Ilse Lenaerts, Pieter J Peeters, Bob Amess, Hassan Rahmoune, Sabine Bahn,[...]. BMC Res Notes 2012
27
11

Stress, depression, and neuroplasticity: a convergence of mechanisms.
Christopher Pittenger, Ronald S Duman. Neuropsychopharmacology 2008
5

Metabolic changes in schizophrenia and human brain evolution.
Philipp Khaitovich, Helen E Lockstone, Matthew T Wayland, Tsz M Tsang, Samantha D Jayatilaka, Arfu J Guo, Jie Zhou, Mehmet Somel, Laura W Harris, Elaine Holmes,[...]. Genome Biol 2008
70
5

Mitochondrial function in the brain links anxiety with social subordination.
Fiona Hollis, Michael A van der Kooij, Olivia Zanoletti, Laura Lozano, Carles Cantó, Carmen Sandi. Proc Natl Acad Sci U S A 2015
112
5

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.
D Martins-de-Souza, P C Guest, L W Harris, N Vanattou-Saifoudine, M J Webster, H Rahmoune, S Bahn. Transl Psychiatry 2012
117
5

Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients.
Ann Gardner, Anna Johansson, Rolf Wibom, Inger Nennesmo, Ulrika von Döbeln, Lars Hagenfeldt, Tore Hällström. J Affect Disord 2003
186
5

Ketogenic diets: from cancer to mitochondrial diseases and beyond.
Ana F Branco, André Ferreira, Rui F Simões, Sílvia Magalhães-Novais, Cheryl Zehowski, Elisabeth Cope, Ana Marta Silva, Daniela Pereira, Vilma A Sardão, Teresa Cunha-Oliveira. Eur J Clin Invest 2016
72
5

β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms.
Lavanya B Achanta, Caroline D Rae. Neurochem Res 2017
101
5

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia.
Elaine Holmes, Tsz M Tsang, Jeffrey T-J Huang, F Markus Leweke, Dagmar Koethe, Christoph W Gerth, Brit M Nolden, Sonja Gross, Daniela Schreiber, Jeremy K Nicholson,[...]. PLoS Med 2006
202
5

Schizophrenia.
Jim van Os, Shitij Kapur. Lancet 2009
5

Neuroketotherapeutics: A modern review of a century-old therapy.
Scott J Koppel, Russell H Swerdlow. Neurochem Int 2018
50
6

Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia.
Ann Katrin Kraeuter, Heather Loxton, Bruna Costa Lima, Donna Rudd, Zoltán Sarnyai. Schizophr Res 2015
27
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.